v3.26.1
Commitments, Contingencies, and Concentration Risk (Details)
 3 Months Ended 12 Months Ended
Feb. 16, 2026
May 15, 2023
USD ($)
May 12, 2023
USD ($)
robot
Jan. 01, 2022
USD ($)
Mar. 31, 2026
USD ($)
robot
shares
Mar. 31, 2025
Dec. 31, 2025
USD ($)
Jan. 09, 2023
USD ($)
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                
Encompass purchase liability         $ 400,000   $ 650,000  
Purchase commitment amount, payments made         373,140   386,663  
Excise tax payable         $ 1,200,000   1,200,000  
Settlement agreement description the Company entered into a settlement agreement to fully settle the Encompass Purchase liability for an aggregate amount of $650,000. The settlement consists of (i) a cash payment of $50,000, (ii) issuance of Company shares with an aggregate fair value of $400,000, and (iii) assignment of a loan liability of $200,000. The Company paid $50,000 per the settlement agreement and recognized a loan liability of $200,000 during the three months ended March 31, 2026. The issuance of Company shares with an aggregate fair value of $400,000 remains pending as of March 31, 2026.              
Purchase Agreement for Telepresence Robots [Member]                
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                
Number of robots purchased (in robot) | robot         20      
Total purchase commitment         $ 711,900      
Unpaid commitment amount         $ 179,900   $ 179,900  
Percentage of monthly revenue generated from telepresence robots, considered for payment     80.00%          
Telepresence robots deployed (in robot) | robot         8      
Total number of deployed telepresence robots (in robot) | robot     11          
Number of robots for which lifetime use payments is to be made (in robot) | robot         125      
Amount paid by investor     $ 352,000          
Equity Incentive Plan 2024 [Member]                
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                
Percentage of shares reserved for issuance         15.00%      
Number of shares issued (in Shares) | shares         2,544,021      
Customer Concentration Risk [Member] | Three Customers [Member] | Accounts Receivable [Member]                
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                
Concentration risk percentage         44.00%   43.00%  
Customer Concentration Risk [Member] | One Customer [Member]                
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                
Concentration risk percentage         24.00% 26.00%    
Supplier Concentration Risk [Member] | Accounts Payable and Accrued Liability [Member]                
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                
Concentration risk percentage             31.00%  
Two Vendor [Member] | Supplier Concentration Risk [Member] | Accounts Payable and Accrued Liability [Member]                
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                
Number of suppliers         40   2  
Investor [Member]                
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                
Number of deployed telepresence robots rights held (in robot) | robot         8      
Percentage of monthly revenue generated from telepresence robots, considered for payment         80.00%      
Investor [Member] | IDoc Virtual Telehealth Solutions, Inc [Member]                
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                
Aggregate principal amount   $ 200,000     $ 200,000      
Number of deployed telepresence robots rights held (in robot)   8            
Percentage of monthly revenue generated from telepresence robots, considered for payment   80.00%            
Telepresence robots deployed (in robot)   8     8      
Encompass Healthcare Billing, LLC [Member] | IDoc Virtual Telehealth Solutions, Inc [Member]                
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                
Business acquisition percentage of voting interests acquired       100.00%        
Encompass for a cash payment       $ 300,000        
Interest expense               $ 45,000
Encompass purchase liability         $ 400,000   $ 650,000  
Minimum [Member] | Investor [Member] | IDoc Virtual Telehealth Solutions, Inc [Member]                
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                
Total number of deployed telepresence robots (in robot)   12     13      
Maximum [Member] | Investor [Member] | IDoc Virtual Telehealth Solutions, Inc [Member]                
Commitments, Contingencies, and Concentration Risk (Details) [Line Items]                
Total number of deployed telepresence robots (in robot)   20     20